Progressive Osseous Heteroplasia (POH) is an extremely rare genetic disorder characterized by the abnormal formation of bone in soft tissues such as muscles and skin. The prevalence of POH is estimated to be less than 1 in 2 million individuals worldwide, making it an exceptionally uncommon condition. This condition typically manifests in early childhood and progressively worsens over time, leading to significant physical limitations and complications. Due to its rarity, POH remains poorly understood, and there is currently no cure available. Early diagnosis and management of symptoms are crucial for individuals affected by this condition.
Progressive Osseous Heteroplasia (POH) is an extremely rare genetic disorder characterized by the abnormal formation of bone in soft tissues such as muscles, tendons, and ligaments. It is estimated that the prevalence of POH is approximately 1 in 2 million individuals worldwide, making it an exceptionally uncommon condition.
POH typically manifests in early childhood and progressively worsens over time. The excessive bone growth can lead to various complications, including limited joint mobility, skeletal deformities, and reduced quality of life. The severity and progression of symptoms can vary among affected individuals.
Due to its rarity, POH often goes undiagnosed or misdiagnosed, leading to challenges in understanding the true prevalence of the disorder. Genetic testing is crucial for accurate diagnosis, as it can identify mutations in the GNAS gene, which is associated with POH.
While there is currently no cure for POH, management focuses on symptom relief and improving quality of life. This may involve physical therapy, surgical interventions, and medications to alleviate pain and complications.
It is important to note that the information provided here is for informational purposes only and should not be considered medical advice. If you suspect you or someone you know may have POH, it is recommended to consult with a qualified healthcare professional for proper diagnosis and guidance.